Clinical Trial Update: Validation of Modified Early Warning Score (MEWS) in Predicting Outcomes in Clinical Oncology Ward Adult Patients

View source ↗

Summary

This update reports on validating the Modified Early Warning Score (MEWS) as a predictor of outcomes in adult cancer patients on an oncology ward.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Oncologic Complications and Emergencies, Cancer | Status: UNKNOWN